Skip to main content
Premium Trial:

Request an Annual Quote

FDA Grants EUAs for Cleveland Clinic COVID-19 PCR Test, Quest Diagnostics Sample Self-Collection Kit

NEW YORK — The US Food and Drug Administration has granted separate Emergency Use Authorizations for a PCR-based SARS-CoV-2 test developed by the Cleveland Clinic and a sample collection kit for COVID-19 testing from Quest Diagnostics.

The Cleveland Clinic's SelfCheck Cobas SARS-CoV-2 Assay is designed to detect the SARS-CoV-2 ORF1ab and E genes in anterior nasal swab specimens self-collected using the SelfCheck COVID-19 Swabbing Kit.

The test runs on Roche's Cobas 6800 and 8800 RT-PCR systems and may only be performed by the Cleveland Clinic.

The Quest Diagnostics Collection Kit for COVID-19 is designed for the at-home collection of anterior nasal swab specimens, which are to be sent to Quest-designated laboratories for molecular testing.

Both institutions have received Emergency Use Authorizations from the FDA for COVID-19 tests in the past. In August, the Cleveland Clinic received EUA for the SelfCheck COVID-19 TaqPath Multiplex PCR test, which uses a sample self-collection kit, and in mid-2020, Secaucus, New Jersey-based Quest received EUA for three SARS-CoV-2 tests that use nasal swab self-collection devices.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.